WEREWOLF THERAPEUTICS, INC. Payments of Financing Costs
WEREWOLF THERAPEUTICS, INC. (HOWL) reported Payments of Financing Costs of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2024-03-07
- WEREWOLF THERAPEUTICS, INC. payments of financing costs for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. payments of financing costs for the quarter ending 2021-03-31 was $559.00K.
- WEREWOLF THERAPEUTICS, INC. payments of financing costs for the quarter ending 2020-03-31 was $0.00.
- WEREWOLF THERAPEUTICS, INC. payments of financing costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- WEREWOLF THERAPEUTICS, INC. payments of financing costs for fiscal 2022 was $88.00K.
- WEREWOLF THERAPEUTICS, INC. payments of financing costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- WEREWOLF THERAPEUTICS, INC. payments of financing costs for fiscal 2020 was $155.00K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 12 month |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-07 | |
| 2022-12-31 | $88.00K 10-K · filed 2024-03-07 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 | |
| 2021-03-31 | $559.00K 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $155.00K 10-K · filed 2022-03-24 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |